Personal
Become a Client
vTv Therapeutics Inc Class A (USD)
VTVT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.68 | 2.77
52-Wk Range- | -
Last Close2.75
Mkt Cap (m)221.82
Dividend yield-
ISINUS9183851057
Volume244,602.00
Exchange VenueNAS

Company Profile

vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes. Its other products include TTP399, type II diabetes drug candidate.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales20.21
P/CF-
Rev Growth (3 year avg)180.38
EPS Growth (3 year avg)-
Operating Margin % -184.78
Net Margin %-132.51
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 14/01/2021
Annual Report
en 31/12/2020

Please refer to the below issuer website for further documents.

https://www.vtvtherapeutics.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)0.520.630.2912.432.766.41
Operating Income (m)-38.14-55.02-50.68-19.82-20.89-11.85
Net Income (m)-27.50-16.35-16.14-7.91-13.04-8.50
Basic EPS-3.32-1.71-1.67-0.69-0.59-0.18
Avg. Diluted Shares Outstanding (m)8.289.559.6912.4530.2947.14
Balance Sheet
USD201520162017201820192020
Current Assets (m)89.1952.1220.363.472.847.22
Non Current Assets (m)2.352.387.565.096.437.57
Total Assets (m)91.5354.5027.928.569.2714.79
Current Liabilities (m)7.7311.4326.9318.8413.386.39
Total Liabilities (m)------
Total Equity (m)-77.97-90.95-151.05-82.85-49.02-80.10
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)-36.95-48.21-44.56-26.86-23.02-18.00
Capital Expenditure (m)-0.10-0.09-0.06-0.01-0.07-
Figures are quoted in USD unless stated otherwise
-
No change
$
2.75
Last Price